CEESAY ABRAHAM (Chief Executive Officer) sold 3.9% of their position (18.92K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $938.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/26/2026ACC: 0001193125-26-368285
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-18.92K
Net shares
Net seller
$938.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.92K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18.92K
Price / share
$49.57
Trade value
$937.96K
% of position
3.9%
8/25/2026
486.11K→467.19K
Total
Net shares
−18.92K
Net value
-$937.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2026 | S · Sale | −18.92K | $49.57 | $937.96K | 3.9% | 486.11K | 467.19K |
| Total | −18.92K | -$937.96K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported